Trials / Recruiting
RecruitingNCT07059923
Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
CT imaging data from lung cancer (NSCLC and SCLC) patients prior to the initiation of immunotherapy (and possibly also after treatment) will be collected. The processing pipeline includes automatic tumor segmentation, radiomics feature extraction, feature selection, and construction of a classification model.
Conditions
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2025-07-11
- Last updated
- 2025-07-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07059923. Inclusion in this directory is not an endorsement.